Skip to main content
. 2014 Jun 26;9(6):e100828. doi: 10.1371/journal.pone.0100828

Table 3. PD patients and control subjects with and without REM-related SDB.

PD patients Control subjects
REM-relatedSDB not REM-relatedSDB p REM-related-SDB not REM-relatedSDB p
(n = 11) (n = 38) (n = 20) (n = 34)
Sex, male 6 (55%) 28 (74%) 0.20 14 (70%) 25 (74%) 0.51
Age, y 63±10 66±7 0.38 61±7 66±7 0.02
BMI, kg/m2 30.2±6.1 26.1±3.7 0.05 28.2±3.6 28.5±5.7 0.79
SAS-SDQ-score 31.6±6.7 34.8±6.9 0.20 38.4±6.7 38.8±6.8 0.83
ESS 6.2±2.4 11.5±5.1 <0.001 12.3±5.7 10.7±4.6 0.31
ESS≥10 1 (9%) 23 (62%) 0.002 15 (75%) 19/32 (59%) 0.20
Disease duration, y 6.1±5.0 10.5±7.2 0.03
UPDRS III 22.4±7.4 27.4±13.4 0.12
RBD 6 (55%) 29 (81%) 0.09
Total sleep, min 363±51 331±59 0.09 350±59 373±51 0.15
Sleep latency to NREM2, min 33.8±21.6 23.5±19.5 0.14 21.8±19.1 28.0±30.5 0.36
Arousal index, /h 6.6±5.7 10.7±8.0 0.07 15.1±10.9 22.8±13.2 0.03
Sleep efficiency, % 81.8±8.7 76.5±12.0 0.12 81.1±12.8 83.2±11.6 0.55
Wake, % 17.7±9.1 23.4±12.0 0.11 18.9±12.8 15.0±7.9 0.23
REM, % 15.5±5.3 15.0±7.0 0.79 12.3±5.7 12.2±4.4 0.95
NREM1, % 12.2±5.3 13.7±9.8 0.91 14.8±10.4 21.4±14.1 0.06
NREM2, % 42.7±9.6 36.4±11.4 0.08 36.8±10.2 37.3±10.0 0.85
SWS, % 11.8±8.2 11.6±8.1 0.93 17.3±6.2 13.6±7.3 0.05
Apnea-hypopjnea index, /h 12.0±4.2 24.8±18.4 0.06 15.9±7.9 26.2±16.5 0.02
Apnea index, /h 2.7±2.2 17.5±15.9 <0.001 10.0±6.5 17.4±14.1 0.09
Obstructive apnea index, /h 2.3±2.2 9.5±12.0 0.01 8.9±5.9 10.4±10.3 0.78
Central apnea index, /h 0.2±0.3 4.2±7.5 0.13 0.3±0.5 3.4±7.8 0.37
Mixed apneaindex, /h 0.2±0.2 4.0±7.7 0.004 0.8±1.1 3.4±4.4 0.01
Hypopnea index, /h 9.3±4.2 7.3±5.9 0.23 6.0±4.1 9.0±7.7 0.19

BMI: body mass index; ESS: Epworth Sleepiness Scale; NREM: non-REM; RBD: REM sleep behavior disorder; REM: rapid eye movement; SaO2: oxygen saturation; SAS-SDQ: Sleep Apnea scale of the Sleep Disorders Questionnaire; SDB: sleep-disordered breathing; SWS: slow wave sleep UPDRS: Unified Parkinson’s Disease Rating Scale.